M4MM

New Jersey Clears Path for $6M Psilocybin Pilot

TRENTON – The New Jersey Legislature gave final approval last week to a measure that sets up a state-backed pilot program for psilocybin therapy, allocating $6 million to explore the compound's role in treating mental ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Operators sharpened their focus on balance sheets and strategic footholds while policymakers grappled with regulatory gaps and emerging threats. Funding flowed into psychedelics innovation, MSOs reported Q3 2025 earnings, trimmed underperformers, and ...

Cronos Group Reports Q3 2025 Financial Results

TORONTO – Cronos Group Inc., a Canadian Cannabis producer with a growing international footprint, reported third-quarter results that marked new highs for revenue, profitability, and cash reserves, even as domestic challenges in Canada tempered some ...

New Jersey Clears Path for $6M Psilocybin Pilot

TRENTON – The New Jersey Legislature gave final approval last week to a measure that sets up a state-backed pilot program for psilocybin therapy, allocating $6 million to explore the compound's role in treating mental ...

Ayr Wellness Inc. Reports Q1 2024 Financial Performance

LOS ANGELES- Ayr Wellness Inc., a vertically integrated U.S. multi-state cannabis operator, has reported significant financial advancements in the first quarter of 2024, underscoring its commitment to sustainable and profitable growth. The company aims to ...

Cresco Labs Reports First Quarter Financial Performance

LOS ANGELES- Cresco Labs reported first-quarter revenues of $184 million, reflecting the company’s growth trajectory in the competitive cannabis market. This increase in revenue is attributed to market expansion and enhanced product offerings under its ...

Subscribe To Our Newsletter